Table of Contents
ISRN Pulmonology
Volume 2011, Article ID 423571, 4 pages
http://dx.doi.org/10.5402/2011/423571
Research Article

Complement C3 Genotype Variants and Risk of Lung Cancer Mortality

1The Copenhagen Male Study, Epidemiological Research Unit, Department of Occupational and Environmental Medicine, Bispebjerg University Hospital, Bispebjerg Bakke 23, 2400 Copenhagen NV, Denmark
2Research Centre for Prevention and Health, Glostrup University Hospital, 2600 Copenhagen, Denmark

Received 3 June 2011; Accepted 7 July 2011

Academic Editor: C. Brambilla

Copyright © 2011 Poul Suadicani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Ardies, “Inflammation as cause for scar cancers of the lung,” Integrative Cancer Therapies, vol. 2, no. 3, pp. 238–246, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Philip, D. A. Rowley, and H. Schreiber, “Inflammation as a tumor promoter in cancer induction,” Seminars in Cancer Biology, vol. 14, no. 6, pp. 433–439, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Knaapen, P. J. A. Borm, C. Albrecht, and R. P. F. Schins, “Inhaled particles and lung cancer. Part A: mechanisms,” International Journal of Cancer, vol. 109, no. 6, pp. 799–809, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Emmendoerffer, M. Hecht, T. Boeker, M. Mueller, and U. Heinrich, “Role of inflammation in chemical-induced lung cancer,” Toxicology Letters, vol. 112-113, pp. 185–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Markiewski and J. D. Lambris, “The role of complement in inflammatory diseases from behind the scenes into the spotlight,” American Journal of Pathology, vol. 171, no. 3, pp. 715–727, 2007. View at Publisher · View at Google Scholar
  6. M. M. Markiewski and J. D. Lambris, “Is complement good or bad for cancer patients? A new perspective on an old dilemma,” Trends in Immunology, vol. 30, no. 6, pp. 286–292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. Markiewski and J. D. Lambris, “Unwelcome complement,” Cancer Research, vol. 69, no. 16, pp. 6367–6370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Okroj, Y. F. Hsu, D. Ajona, R. Pio, and A. M. Blom, “Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors,” Molecular Immunology, vol. 45, no. 1, pp. 169–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Jurianz, S. Ziegler, H. Garcia-Schüler et al., “Complement resistance of tumor cells: basal and induced mechanisms,” Molecular Immunology, vol. 36, no. 13-14, pp. 929–939, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Yates, T. Sepp, B. K. Matharu et al., “Complement C3 variant and the risk of age-related macular degeneration,” New England Journal of Medicine, vol. 357, no. 6, pp. 553–561, 2007. View at Publisher · View at Google Scholar
  11. J. E. Finn, L. Zhang, S. Agrawal, D. R. W. Jayne, D. B. G. Oliveira, and P. W. Mathieson, “Molecular analysis of C3 allotypes in patients with systemic vasculitis,” Nephrology Dialysis Transplantation, vol. 9, no. 11, pp. 1564–1567, 1994. View at Google Scholar · View at Scopus
  12. J. E. Finn and P. W. Mathieson, “Molecular analysis of C3 allotypes in patients with nephritis factor,” Clinical and Experimental Immunology, vol. 91, no. 3, pp. 410–414, 1993. View at Google Scholar · View at Scopus
  13. F. Gyntelberg, “Physical fitness and coronary heart disease in male residents in Copenhagen aged 40–59,” Danish Medical Bulletin, vol. 20, no. 1, pp. 1–4, 1973. View at Google Scholar · View at Scopus
  14. F. Gyntelberg, “One and two years incidence of myocardial infarction in Copenhagen males aged 40–59,” Danish Medical Bulletin, vol. 22, no. 2, pp. 81–84, 1975. View at Google Scholar · View at Scopus
  15. P. Teisberg, “High voltage agarose gel electrophoresis in the study of C′3 polymorphism,” Vox Sanguinis, vol. 19, no. 1, pp. 47–56, 1970. View at Google Scholar · View at Scopus
  16. A. E. Mourant, A. C. Kopec, and K. Damaniewska-Sobcnoak, The Distribution of the Human Blood Groups and Other Polymorphisms, Oxford University Press, London, UK, 1976.
  17. P. Suadicani, H. O. Hein, and F. Gyntelberg, “Serum cotinine validated form of smoking does not account for social inequalities in risk of ischaemic heart disease: the Copenhagen Male Study—4 years' follow-up,” International Journal of Epidemiology, vol. 23, pp. 293–300, 1994. View at Google Scholar
  18. D. R. Cox, “Regression models and life-tables,” Journal of the Royal Statistical Society. B, vol. 37, no. 2, pp. 187–220, 1972. View at Google Scholar · View at Scopus
  19. P. Suadicani, H. O. Hein, and F. Gyntelberg, “ABO phenotypes and inflammation-related predictors of lung cancer mortality: the Copenhagen Male Study—a 16-year follow-up,” European Respiratory Journal, vol. 30, no. 1, pp. 13–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. P. G. Fabricius and P. Lange, “Diet and lung cancer,” Ugeskrift for Laeger, vol. 165, no. 34, pp. 3234–3237, 2003 (Danish). View at Google Scholar